Position in NVS
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$11,087,156
+$362,427 QoQ
Shares Held
70,745
+0.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.80%
of 13F equity value
Holder Rank
#165
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAMDEN NATIONAL BANK holds $48,743,727 across 8 Drug Manufacturers - General names. NVS ranks #3 (22.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
69,914 | $17,756,057 | |
| 2 | MRK |
Merck & Co., Inc.
|
113,039 | $14,525,511 | |
| 3 | NVS |
Novartis AG
This page
|
70,745 | $11,087,156 | |
| 4 | ABBV |
AbbVie Inc.
|
9,869 | $2,483,434 | |
| 5 | LLY |
ELI LILLY & Co
|
1,578 | $1,892,700 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,850 | $360,068 | |
| 7 | PFE |
Pfizer Inc
|
14,370 | $346,029 | |
| 8 | AZN |
Astrazeneca PLC
|
1,544 | $292,772 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,087,156 | 70,745 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $10,724,729 | 70,211 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $9,770,708 | 70,869 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $9,056,564 | 70,622 | Shares | Defined | 2025-11-06 | |
| 2025-06-30 | $8,598,607 | 71,057 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $8,060,894 | 72,308 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $7,153,159 | 73,509 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $8,504,348 | 73,938 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $8,025,167 | 75,382 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $6,296,348 | 65,092 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $6,713,999 | 66,495 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $6,828,286 | 67,036 | Shares | Defined | 2023-11-03 | |
| 2023-06-30 | $6,814,148 | 67,527 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $6,320,492 | 68,701 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $6,185,470 | 68,182 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $5,202,351 | 68,443 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $5,759,451 | 68,135 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $5,827,564 | 66,411 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $5,784,040 | 66,126 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,447,692 | 66,614 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $5,946,566 | 65,175 | Shares | Defined | 2021-08-09 | |
| 2021-03-31 | $5,623,643 | 65,789 | Shares | Defined | 2021-08-04 | |
| 2020-12-31 | $6,270,907 | 66,408 | Shares | Defined | 2021-02-01 | |
| 2020-09-30 | $5,994,673 | 68,936 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $5,974,055 | 68,400 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $5,625,810 | 68,233 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||